These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20961861)

  • 1. Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.
    Maasch C; Vater A; Buchner K; Purschke WG; Eulberg D; Vonhoff S; Klussmann S
    J Biol Chem; 2010 Dec; 285(51):40012-8. PubMed ID: 20961861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.
    Watanabe M; Sheriff S; Lewis KB; Tinch SL; Cho J; Balasubramaniam A; Kennedy MA
    Cancer Lett; 2012 Feb; 315(1):18-27. PubMed ID: 22036895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Liau SS; Jazag A; Ito K; Whang EE
    Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA and Cancer: A Review on Patent Literatures.
    De Martino M; Fusco A; Esposito F
    Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.
    Akhter MZ; Luthra K; Rajeswari MR
    J Biomol Struct Dyn; 2016; 34(4):877-91. PubMed ID: 26084422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.
    Grant MA; Baron RM; Macias AA; Layne MD; Perrella MA; Rigby AC
    Biochem J; 2009 Feb; 418(1):103-12. PubMed ID: 18937643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
    Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy.
    Hassan F; Lossie SL; Kasik EP; Channon AM; Ni S; Kennedy MA
    PLoS One; 2018; 13(2):e0192882. PubMed ID: 29462157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for therapeutic applications.
    Maasch C; Buchner K; Eulberg D; Vonhoff S; Klussmann S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):61-2. PubMed ID: 18776253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).
    Battista S; Fedele M; Martinez Hoyos J; Pentimalli F; Pierantoni GM; Visone R; De Martino I; Croce CM; Fusco A
    Biochem J; 2005 Jul; 389(Pt 1):91-7. PubMed ID: 15713121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation.
    Hoehlig K; Johnson KW; Pryazhnikov E; Maasch C; Clemens-Smith A; Purschke WG; Vauléon S; Buchner K; Jarosch F; Khiroug L; Vater A; Klussmann S
    Br J Pharmacol; 2015 Jun; 172(12):3086-98. PubMed ID: 25659966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(®) therapeutics.
    Vater A; Klussmann S
    Drug Discov Today; 2015 Jan; 20(1):147-55. PubMed ID: 25236655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.
    Baldassarre G; Belletti B; Battista S; Nicoloso MS; Pentimalli F; Fedele M; Croce CM; Fusco A
    Oncogene; 2005 Oct; 24(45):6809-19. PubMed ID: 16007157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The High Mobility Group A1 (HMGA1) Chromatin Architectural Factor Modulates Nuclear Stiffness in Breast Cancer Cells.
    Senigagliesi B; Penzo C; Severino LU; Maraspini R; Petrosino S; Morales-Navarrete H; Pobega E; Ambrosetti E; Parisse P; Pegoraro S; Manfioletti G; Casalis L; Sgarra R
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
    Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
    Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells.
    Kim YH; Sung HJ; Kim S; Kim EO; Lee JW; Moon JY; Choi K; Jung JE; Lee Y; Koh SS; Rhee SG; Heo K; Kim IH
    Cancer Lett; 2011 Dec; 313(1):76-83. PubMed ID: 21963224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
    D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
    BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.